Purinergic regulation of renal function - physiology, pathophysiology and experimental therapeutics. Role of purinergic signaling in diet-induced obesity and insulin resistance.
- M.B., B.S., Basic & Clinical Medicine, Kurnool Medical College, Sri Venkateswara University, Tirupathi, India
- M.D., Medical Biochemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
- Ph.D. (Docteur en Sciences Biomédicales), Cellular and Molecular Pharmacology & Toxicology Unit, Christian de Duve Inst. of Cellular Pathology, and Catholic University of Louvain, Brussels, Belgium
- Executive MBA, Executive Business Administration, David Eccles School of Business, University of Utah, Salt Lake City, Utah
Bellamkonda K. Kishore is a Research Professor of Medicine at the University of Utah Health Sciences Center, and Principal Investigator (Nephrology) at the George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah. He is also an Adjunct Associate Professor of Nutrition and Integrative Physiology and a Member of the Center on Aging at the University of Utah. During the past three decades Dr. Kishore has been pursuing research in renal physiology, pathophysiology and experimental therapeutics in India, Japan, Belgium and the USA. He and his collaborators hold international patents (issued or pending) to develop innovative therapies for erythropoietin-responsive anemia, water balance disorders, diet-induced obesity and insulin resistance, and autosomal dominant polycystic kidney disease (ADPKD). His distinctions include induction as Chartered Biologist (CBiol) and Fellow of the Royal Society of Biology (FRSB), London, UK, Fellow of the American Society of Nephrology (FASN), Premium Professional Gold Heart Member of the American Heart Association (Member of the Councils on Kidney in Cardiovascular Diseases & Basic Cardiovascular Sciences), and Member of the Faculty of 1000 - Prime & Research (Renal Fluid & Electrolyte Physiology); citations in the European Biographical Directory, and Who’sWho in Medicine and Healthcare (USA). He is an active member of the American Society of Nephrology, American Physiological Society, and International Society of Nephrology. He is a member of the Editorial Boards of the American Journal of Physiology (Renal Physiology; since 2002), Open Urology and Nephrology Journal (Bentham), Open Journal of Nephrology (SCIRP), Journal of Medical Disorders (Herbert), and Journal of Nephrology and Renal Therapies (Herald). He also served as Guest Associate Editor for the Frontiers in Physioloty (Renal and Epithelial Physiology). He is an expert reviewer for the US National Institutes of Health and the Department of Veterans Affairs, as well as organizations and foundations in the USA, United Kingdom, Italy, Denmark, The Netherlands, Singapore and India. He traveled extensively in Europe and the USA to present communications or to chair scientific sessions at international conferences or to deliver invited lectures at various academic institutes. He has been actively participating in research mentoring of undergraduate students and UROP Program at the University of Utah, and Frontiers in Physiology Program of the American Physiological Society. His hobbies include art, writing, photography, travel and promotion of cultural, alumni and diversity activities.
Kishore B, Westenfelder C, Isaac J. Composition and Methods Related to Production of Erythropoietin. USPTO Permanent Patent # 8,084,423, issued on 12/27/2011
Kishore B, Carlson N, Kohan D, Nelson R. Methods and Composition for Treating Nephrogenic Diabetes Insipidus. PCT/US2005/0323 (Pending); European Patents (France, Germany, United Kingdom) issued on 3/28/2012
Kishore B, Carlson N, Zhang Y. Methods and Composition for Treating Acquired Nephrogenic Diabetes Insipidus. Permanent Patent # 9,539,246, issued on 01/10/2017
Kishore B, Zhang Y, Ecelbarger C. Composition and Methods for the Prevention and Treatment of Diet-induced Obesity. PCT/US2012/61/795,815 (Pending)
Kishore B, Zhang Y, Carlson N. Treatment of Autosomal Dominant Polycystic Kidney Disease. U.S. Patent Application # 62/452,841 (Filed on 02/19/2017)